In the clinic. Breast cancer screening and prevention.
Nattinger
Ann B
AB
D000367:Age Factors; D001943:Breast Neoplasms / Q000000981:diagnostic imaging* / Q000517:prevention & control*; D003362:Cost-Benefit Analysis; D004965:Estrogen Antagonists / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008327:Mammography / Q000191:economics; D008403:Mass Screening / Q000191:economics / Q000379:methods*; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use; D012307:Risk Factors; D013629:Tamoxifen / Q000627:therapeutic use; D013997:Time Factors
D004965:Estrogen Antagonists; D013629:Tamoxifen; D020849:Raloxifene Hydrochloride